Page last updated: 2024-08-24

zolmitriptan and Amphetamine-Related Disorders

zolmitriptan has been researched along with Amphetamine-Related Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cotter, AR; Garcia, R; Leslie, K; Neisewander, JL; Olive, MF	1

Other Studies

1 other study(ies) available for zolmitriptan and Amphetamine-Related Disorders

Article	Year
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders. The international journal of neuropsychopharmacology, 2017, 08-01, Volume: 20, Issue:8 Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Oxazolidinones; Pyridines; Random Allocation; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Reinforcement Schedule; Serotonin 5-HT1 Receptor Agonists; Tryptamines	2017

Article

Year

Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.

The international journal of neuropsychopharmacology, 2017, 08-01, Volume: 20, Issue:8

Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Oxazolidinones; Pyridines; Random Allocation; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Reinforcement Schedule; Serotonin 5-HT1 Receptor Agonists; Tryptamines

2017